China conflict results raise in Covid Medicine price | Oneindia Kannada
ಭಾರತ ಚೀನಾ ನಡುವಿನ ಕಿರಿಕಿರಿ ಮತ್ತಷ್ಟು ಸಂಕಷ್ಟ ತಂದಿದೆ . ಆದರೆ ಈ ಬಾರಿ ಅದು ಬಾರ್ಡರ್ ನಲ್ಲಿ ಅಲ್ಲ ಬದಲಿಗೆ ಆಸ್ಪತ್ರೆಗಳಲ್ಲಿ . ಇದರಿಂದ ಔಷಧಿಗಳ ಬೆಲೆಯಲ್ಲಿ ಏರಿಕೆಯಾಗಿದೆ .
The National Pharmaceutical Pricing Authority (NPPA) has allowed a one-time price increase of 50% on the present ceiling price of Heparin injection – used in treatment of COVID-19 patients – after shortage in supply of raw material for the injection from China and substantial hike in its input cost hit companies manufacturing the drug in India.
The National Pharmaceutical Pricing Authority (NPPA) has allowed a one-time price increase of 50% on the present ceiling price of Heparin injection – used in treatment of COVID-19 patients – after shortage in supply of raw material for the injection from China and substantial hike in its input cost hit companies manufacturing the drug in India.
Category
🗞
News